SPONSOR
First Affiliated Hospital Xi'an Jiaotong University
Total Trials
8
Recruiting
8
Phases
Phase 4, EARLY_Phase 1, Phase 3
Conditions studied: Kidney TransplantCOVID-19Post-COVID-19 SyndromeAcute COVID-19Post-Acute COVID-19Homozygous Familial HypercholesterolemiaType A Aortic DissectionComplication of Surgical ProcedureAortic DiseasesAPL
First Affiliated Hospital Xi'an Jiaotong University is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Kidney Transplant, COVID-19, Post-COVID-19 Syndrome, Acute COVID-19.
The trial portfolio spans Phase 4, EARLY_Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — First Affiliated Hospital Xi'an Jiaotong University
How many clinical trials has First Affiliated Hospital Xi'an Jiaotong University sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by First Affiliated Hospital Xi'an Jiaotong University, of which 8 are actively recruiting participants. These trials cover conditions including Kidney Transplant, COVID-19, Post-COVID-19 Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does First Affiliated Hospital Xi'an Jiaotong University research focus on?
First Affiliated Hospital Xi'an Jiaotong University clinical trials span Kidney Transplant, COVID-19, Post-COVID-19 Syndrome, Acute COVID-19, Post-Acute COVID-19, and additional conditions. The research pipeline includes Phase 4, EARLY_Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a First Affiliated Hospital Xi'an Jiaotong University clinical trial?
To participate in a First Affiliated Hospital Xi'an Jiaotong University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all First Affiliated Hospital Xi'an Jiaotong University trials with current recruitment status updated daily.
Clinical Trials by First Affiliated Hospital Xi'an Jiaotong University
NCT07266467 Phase 4
Recruiting
Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients
Kidney Transplant
NCT05745805
Recruiting
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
COVID-19
NCT06125847 EARLY_Phase 1
Recruiting
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
Homozygous Familial Hypercholesterolemia
NCT06199401
Recruiting
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
Type A Aortic Dissection
NCT07503730 Phase 3
Recruiting
Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).
APL
NCT06567938
Recruiting
Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease
Coronary Artery Disease
NCT06352320
Recruiting
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH）
Cardiomyopathies
NCT06010199
Recruiting
Risk Stratification Value of Biomarkers in Patients With Myocarditis
Myocarditis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology